Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, received a high -ranking Saudi delegation headed by Dr. Hisham Al -Jeddi, CEO of the Saudi Food and Drug General Authority, in the presence of Dr. Tariq Al -Houbi, Chairman of the National Food Safety Authority, on a visit aimed at expanding the areas of technical and organizational cooperation in the pharmaceutical sector, and exchanging experiences in a way that enhances the regulatory and industrial integration between the two countries The two brothers. With the siblings from the Kingdom of Saudi Arabia, he said: We are highly valued your presence today, and that your visit reflects the cooperation and partnership that brings us together to achieve common goals and interests, and its purpose is to serve our generous peoples.
The head of the authority explained that the Egyptian relations & ndash; Saudi Arabia throughout history as an integrated strategic partnership, which includes political, economic and cultural dimensions, and translates into a common vision to achieve sustainable development and upgrade the standard of living of our noble peoples, and with regard to the drug sector, which is one of the most vital and strategic sectors, Dr. confirmed. Al -Ghamrawi is that the Arab Republic of Egypt and the Kingdom of Saudi Arabia lead the scene within the Arab nation and the Middle East region; As the Kingdom and Egypt exchange the first and second place in terms of market value and the number of units sold, and this puts on us a double responsibility towards our peoples and the peoples of the region, especially in light of the global health challenges. Strategists, we have the ability to meet the needs of our markets and enhance our drug security, especially since the Egyptian and Saudi markets are among the largest importers of raw materials in the Middle East and Africa. International credits, in addition to 150 medical supplies factories, 5 factories specialized in raw materials and 4 biomedically specialized factories, and more than 986 production lines for drugs, and that the efforts of the Egyptian state, during the past years, have contributed to enhancing our technical and productive capabilities; This enabled us to achieve a self -sufficiency rate of 91% of the needs of the local market, as well as export to 147 countries around the world. Today we want a real opportunity to draw a common road map, with clear plans, and a specific time frame, which reflects the aspirations of our leaders, and meets the hopes of our citizens in effective and sustainable drug integration & quot; & nbsp;
& nbsp;
for his part, Dr. Hisham Al -Jedi, CEO of the General Food and Drug Authority, delivered a word He expressed his happiness with this constructive meeting, noting that cooperation with the Egyptian Pharmaceutical Authority represents a leading model for Arab integration in the organizational field, stressing the importance of unifying efforts to enhance the capabilities of regulatory bodies and support the quality and safety of pharmaceutical products in the region. Regular, to ensure the conversion of visions into a tangible reality, which pushes the march of the Egyptian cooperation & ndash; The two countries, and to explore the possibility of developing common early warning tools, organizing mutual training workshops between the two bodies, to enhance capacity building and exchange experiences in a manner that serves common interests, and to appoint an official contact point from both sides to facilitate continuous coordination and follow -up.
participated in the meeting by the Egyptian Pharmaceutical Authority, Dr. Tamer Al -Husseini, Vice -Chairman of the Egyptian Pharmaceutical Authority, d. Muhammad Al -Demerdash, Deputy State Council and Legal Adviser to the Authority, d. Amani Jawdat, Assistant Commander of the Authority and the supervisor of the Central Administration of the Office of the Chairman of the Authority, d. Hanan Amin, Head of the Central Administration for Pharmaceutical Programs, d. Asma Fouad, Head of the Central Administration for Biological and Innovative Prospects and Clinical Studies, Dr. Amira Mahjoub, President of the Central Operations Department, d. Osama Hatem, Associate Chairman of the Authority for Policies and International Cooperation and the supervisor of the Central Administration for Drug Policy and Market Support, d. Dalia Abu Hussein, Director General of the General Administration for Quality Confirmation. Muhammad bin Ali Dahas, Assistant Deputy Vice President of the Branches and Inspection, Abdulaziz bin Suleiman, the head of the international operations department, Faisal bin Muhammad al -Dhahidif, the first organizational affairs, Taghreed bint Ali al -Humaidhi, a researcher with international law, Faisal bin Abdulaziz Al -Askar, Director of the Carties Administration, Saad bin Mansour Al -Qahtani, the first of the first.
- For more: Elrisala website and for social networking, you can follow us on Facebook
- Source of information and images “rosaelyoussef”“
